Document Detail


New approaches to blockade of the renin-angiotensin-aldosterone system: mineralocorticoid-receptor blockers exert antihypertensive and renoprotective effects independently of the renin-angiotensin system.
MedLine Citation:
PMID:  20675957     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The role of angiotensin II in mediating hypertension and renal diseases is well documented, and inhibition of the renin-angiotensin-aldosterone system elicits antihypertensive and renoprotective effects. There is increasing evidence implicating aldosterone, in addition to angiotensin II, in the pathogenesis of hypertension and renal diseases. Beneficial effects of mineralocorticoid receptor (MR) blockers against these diseases have been reported and are independent of the effects exerted by renin-angiotensin system (RAS) inhibitors. MR blockers are increasingly being used, not only for primary aldosteronism but also for other resistant hypertensive patients whose blood pressure is insufficiently controlled by RAS inhibitors. In these settings, MR blockers have shown impressive results. In addition, anti-proteinuric effects of MR blockers have been observed in hypertensive patients treated with RAS inhibitors, but without significant effects on blood pressure. Interestingly, these effects of MR blockers are not always dependent on plasma aldosterone levels. These data suggest that MR blockers provide a potential therapeutic approach for patients with hypertension and renal impairment who are being treated with RAS inhibitors.
Authors:
Akira Nishiyama; Koichi Hasegawa; Suwarni Diah; Hirofumi Hitomi
Related Documents :
3010707 - Humoral effects of long-term oral enalapril therapy.
16330897 - Role of angiotensin ii in the evolution of diastolic heart failure.
10218547 - Mineralocorticoid hypertension.
3050197 - Periodic fluctuation of blood pressure and its management in a patient with pheochromoc...
19568677 - Passive flow-rate regulators using pressure-dependent autonomous deflection of parallel...
7124947 - Sodium transport in the rabbit connecting tubule.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2010-07-27
Journal Detail:
Title:  Journal of pharmacological sciences     Volume:  113     ISSN:  1347-8648     ISO Abbreviation:  J. Pharmacol. Sci.     Publication Date:  2010  
Date Detail:
Created Date:  2010-08-20     Completed Date:  2010-12-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101167001     Medline TA:  J Pharmacol Sci     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  310-4     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Faculty of Medicine, Kagawa University, Kita-gun, Japan. akira@kms.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / pharmacology*,  therapeutic use
Humans
Hypertension / drug therapy
Kidney / drug effects
Receptors, Mineralocorticoid / antagonists & inhibitors*
Renin-Angiotensin System / drug effects*
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Receptors, Mineralocorticoid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New approaches to blockade of the renin-angiotensin-aldosterone system: evidence from randomized con...
Next Document:  New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important targ...